Literature DB >> 11694400

Myelodysplastic syndromes: recent advances.

E P Alessandrino1, S Amadori, M Cazzola, F Locatelli, C Mecucci, E Morra, G Saglio, G Visani, S Tura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11694400

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

Review 1.  Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research.

Authors:  Ting Zhou; Marsha C Kinney; Linda M Scott; Sandra S Zinkel; Vivienne I Rebel
Journal:  Blood       Date:  2015-06-15       Impact factor: 22.113

2.  Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.

Authors:  Yang Du; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

3.  Juvenile myelomonocytic leukemia.

Authors:  Neha Sethi; Shivani Kushwaha; Bhawana Dhingra; Mukta Pujani; Jagdish Chandra; Shailaja Shukla
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-10       Impact factor: 0.900

4.  EVI1 induces myelodysplastic syndrome in mice.

Authors:  Silvia Buonamici; Donglan Li; Yiqing Chi; Rui Zhao; Xuerong Wang; Larry Brace; Hongyu Ni; Yogen Saunthararajah; Giuseppina Nucifora
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

5.  EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation.

Authors:  Xiangbin Xu; Chang-Hoon Woo; Rachel R Steere; Byung Cheol Lee; Yuxian Huang; Jing Wu; Jinjiang Pang; Jae Hyang Lim; Haidong Xu; Wenhong Zhang; Anuhya S Konduru; Chen Yan; Michael T Cheeseman; Steve D M Brown; Jian-Dong Li
Journal:  J Immunol       Date:  2012-05-11       Impact factor: 5.422

6.  Annotating function to differentially expressed LincRNAs in myelodysplastic syndrome using a network-based method.

Authors:  Keqin Liu; Dominik Beck; Julie A I Thoms; Liang Liu; Weiling Zhao; John E Pimanda; Xiaobo Zhou
Journal:  Bioinformatics       Date:  2017-09-01       Impact factor: 6.937

Review 7.  Managing myelodysplastic symptoms in elderly patients.

Authors:  R Ria; M Moschetta; A Reale; G Mangialardi; A Castrovilli; A Vacca; F Dammacco
Journal:  Clin Interv Aging       Date:  2009-11-18       Impact factor: 4.458

Review 8.  Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea.

Authors:  Jong Wook Lee
Journal:  Int J Hematol       Date:  2008-07-05       Impact factor: 2.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.